<table class="drug-table data-table table table-condensed table-bordered"><tbody><tr id="identification"><th class="divider" colspan="2">Identification</th></tr><tr><th>Name</th><td><strong>Iron Dextran</strong></td></tr><tr><th>Accession Number</th><td><strong>DB00893</strong>&#160; (APRD01053)</td></tr><tr><th>Type</th><td>small molecule</td></tr><tr><th>Groups</th><td>approved</td></tr><tr><th>Description</th><td><p>Iron dextran is a dark brown, slightly viscous liquid complex of ferric hydroxide and dextran for intravenous or intramuscular use. Iron Dextran is used for the treatment of patients with documented iron deficiency in which oral administration is unsatisfactory or impossible.</p></td></tr><tr><th>Structure</th><td><div class="structure"><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DB00893/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DB00893/thumb.png"></a></div><div class="structure-links"><div class="btn-group btn-group-xs"><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00893.mol">MOL</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00893.sdf">SDF</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00893.pdb">PDB</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00893.smiles">SMILES</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00893.inchi">InChI</a><a class="btn btn-info" href="/structures/structures/small_molecule_drugs/DB00893">View Structure</a></div></div></td></tr><tr><th>Synonyms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="synonyms"><thead><th>Synonym</th><th>Language</th><th>Code</th></thead><tbody><tr><td>Dexferrum</td><td>Latin</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Dextran iron</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table></td></tr><tr><th>Salts</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Brand names</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="brands"><thead><tr><th>Name</th><th>Company</th></tr></thead><tbody><tr><td>CosmoFer</td><td>B. Braun</td></tr><tr><td>DexIron</td><td>Mylan Pharmaceuticals ULC</td></tr><tr><td>Feosol</td><td>GlaxoSmithKline</td></tr><tr><td>Imferon</td><td>Sanofi-Aventis</td></tr><tr><td>Infed</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Proferdex</td><td>New River Pharmaceuticals Inc.</td></tr></tbody></table></td></tr><tr><th>Brand mixtures</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="mixtures"><thead><tr><th>Brand Name</th><th>Ingredients</th></tr></thead><tbody><tr><td>Omni 2000tab</td><td>Beta-Carotene + Biotin + Calcium (Bone Meal) + Choline + Chromium (Yeast) + D-Pantothenic Acid + Folic Acid + Inositol + Iodine (Kelp) + Iron (Iron Dextran Complex) + Magnesium (Magnesium Oxide) + Manganese (Manganese Gluconate) + Molybdenum (Yeast) + Nicotinamide + Potassium (Potassium Gluconate) + Selenium (Yeast) + Vitamin a (Fish Liver Oil) + Vitamin B1 + Vitamin B12 + Vitamin B2 + Vitamin B6 (Pyridoxine Hydrochloride) + Vitamin C (Calcium Ascorbate) + Vitamin C (Vitamin C) + Vitamin D3 + Vitamin E (D-Alpha Tocopheryl Acetate) + Zinc (Zinc Gluconate)</td></tr></tbody></table></td></tr><tr><th>Categories</th><td><ul><li><a href="/mesh/hematinics">Hematinics</a></li>
<li><a href="/mesh/anti-anemic-agents">Anti-anemic Agents</a></li>
<li><a href="/mesh/supplements">Supplements</a></li></ul></td></tr><tr><th>CAS number</th><td>9004-66-4</td></tr><tr><th>Weight</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Chemical Formula</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>InChI Key</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>InChI</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>IUPAC Name</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SMILES</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Mass Spec</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="taxonomy"><th class="divider" colspan="2">Taxonomy</th></tr><tr><th>Kingdom</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Superclass</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Class</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Subclass</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Direct parent</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Alternative parents</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Substituents</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Classification description</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="pharmacology"><th class="divider" colspan="2">Pharmacology</th></tr><tr><th>Indication</th><td>For treatment of patients with documented iron deficiency in whom oral administration is unsatisfactory or impossible. Also used to replenish body iron stores in Non-Dialysis Dependent-Chronic Kidney Disease (NDD-CKD) patients receiving or not receiving erythropoietin and in Hemodialysis Dependent (HDD-CKD) and Peritoneal Dialysis Dependent (PDD-CKD) - Chronic Kidney Disease patients receiving an erythropoietin.</td></tr><tr><th>Pharmacodynamics</th><td>Iron dextran is a dark brown, slightly viscous sterile liquid complex of ferric hydroxide and dextran for intravenous or intramuscular use. It is for treatment of patients with documented iron deficiency in whom oral administration is unsatisfactory or impossible. Iron is essential to the formation of hemoglobin and to the function and formation of other heme and nonheme compounds. Untreated depletion of iron stores leads to iron-deficient erythropoiesis and, in turn, to iron deficiency anemia.</td></tr><tr><th>Mechanism of action</th><td>After iron dextran is injected, the circulating iron dextran is removed from the plasma by cells of the reticuloendothelial system, which split the complex into its components of iron and dextran. The iron is immediately bound to the available protein moieties to form hemosiderin or ferritin, the physiological forms of iron, or to a lesser extent to transferrin. This iron which is subject to physiological control replenishes hemoglobin and depleted iron stores.</td></tr><tr><th>Absorption</th><td>The major portion of intramuscular injections of iron dextran is absorbed within 72 hours; most of the remaining iron is absorbed over the ensuing 3 to 4 weeks.</td></tr><tr><th>Volume of distribution</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Protein binding</th><td>100% (after release from dextran)</td></tr><tr><th>Metabolism</th><td class="data-table-container"><p>Dextran, a polyglucose, is either metabolized or excreted.</p></td></tr><tr><th>Route of elimination</th><td>Dextran, a polyglucose, is either metabolized or excreted.</td></tr><tr><th>Half life</th><td>5 hours (some indications that it can be as long as 10 hours)</td></tr><tr><th>Clearance</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Toxicity</th><td>LD<sub>50</sub> = 500 mg/kg (mouse, IV). Dosages of iron dextran in excess of the requirements for restoration of hemoglobin and replenishment of iron stores may lead to hemosiderosis. Cases of severe, sometimes fatal, allergic reactions (loss of consciousness, collapse, difficulty breathing, hives, swelling, or convulsions) and severe low blood pressure (hypotension) have been reported with the use of iron dextran.</td></tr><tr><th>Affected organisms</th><td><ul><li>Humans and other mammals</li></ul></td></tr><tr><th>Pathways</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Effects</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Adverse Drug Reactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="admet"><th class="divider" colspan="2">ADMET</th></tr><tr><th>Predicted ADMET features</th><td class="data-table-container"><table class="table table-condensed table-striped" id="predicted-admet">
  <thead>
    <tr>
      <th>Property</th>
      <th>Value</th>
      <th>Probability</th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>Human Intestinal Absorption</td>
        <td>
              <span class="wishart wishart-not-available">Not Available</span>
        </td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
      </tr>
      <tr>
        <td>Blood Brain Barrier</td>
        <td>
              <span class="wishart wishart-not-available">Not Available</span>
        </td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
      </tr>
      <tr>
        <td>Caco-2 permeable</td>
        <td>
              <span class="wishart wishart-not-available">Not Available</span>
        </td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
      </tr>
      <tr>
        <td>P-glycoprotein substrate</td>
        <td>
            <span class="wishart wishart-not-available">Not Available</span>
        </td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor I</td>
        <td>
            <span class="wishart wishart-not-available">Not Available</span>
        </td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor II</td>
        <td>
            <span class="wishart wishart-not-available">Not Available</span>
        </td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
      </tr>
      <tr>
        <td>Renal organic cation transporter</td>
        <td>
            <span class="wishart wishart-not-available">Not Available</span>
        </td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
      </tr>
      <tr>
        <td>CYP450 1A2 substrate</td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
      </tr>
      <tr>
        <td>CYP450 2C19 substrate</td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
      </tr>
      <tr>
        <td>CYP450 inhibitory promiscuity</td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
      </tr>
      <tr>
        <td>Ames test</td>
        <td>
          <span class="wishart wishart-not-available">Not Available</span> 
        </td>
        <td>
            <span class="wishart wishart-not-available">Not Available</span>
        </td>
      </tr>
      <tr>
        <td>Carcinogenicity</td>
        <td>
          <span class="wishart wishart-not-available">Not Available</span> 
        </td>
        <td>
            <span class="wishart wishart-not-available">Not Available</span>
        </td>
      </tr>
      <tr>
        <td>Biodegradation</td>
        <td>
          <span class="wishart wishart-not-available">Not Available</span> 
        </td>
        <td>
            <span class="wishart wishart-not-available">Not Available</span>
        </td>
      </tr>
      <tr>
        <td>Rat acute toxicity</td>
        <td>
          <span class="wishart wishart-not-available">Not Available</span> 
        </td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor I)</td>
        <td>
          <span class="wishart wishart-not-available">Not Available</span> 
        </td>
        <td>
            <span class="wishart wishart-not-available">Not Available</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor II)</td>
        <td>
          <span class="wishart wishart-not-available">Not Available</span> 
        </td>
        <td>
            <span class="wishart wishart-not-available">Not Available</span>
        </td>
      </tr>
  </tbody>
</table>
</td></tr><tr id="pharmacoeconomics"><th class="divider" colspan="2">Pharmacoeconomics</th></tr><tr><th>Manufacturers</th><td><ul><li>Luitpold pharmaceuticals inc</li>
<li>Watson laboratories inc</li>
<li>Sanofi aventis us llc</li>
<li>New river pharmaceuticals inc</li></ul></td></tr><tr><th>Packagers</th><td><ul><li><a href="http://www.alavenpharm.com">Alaven Pharmaceutical</a></li>
<li><a href="http://www.americanregent.com">American Regent</a></li>
<li><a href="http://www.giv.com">General Injectables and Vaccines Inc.</a></li>
<li><a href="http://gensavis.com">Gensavis LLC</a></li>
<li><a href="http://www.luitpold.com">Luitpold Pharmaceuticals Inc.</a></li>
<li><a href="http://www.patheon.com">Patheon Inc.</a></li>
<li><a href="http://www.physicianstotalcare.com">Physicians Total Care Inc.</a></li>
<li>Primedics Laboratories</li>
<li>Schein Pharmaceutical Inc.</li>
<li><a href="http://www.watson.com">Watson Pharmaceuticals</a></li></ul></td></tr><tr><th>Dosage forms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="dosages"><thead><tr><th>Form</th><th>Route</th><th>Strength</th></tr></thead><tbody><tr><td>Injection, solution</td><td>Intramuscular</td><td></td></tr><tr><td>Injection, solution</td><td>Intravenous</td><td></td></tr></tbody></table></td></tr><tr id="spectra"><th class="divider" colspan="2">Spectra</th></tr><tr><th>Spectra</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="interactions"><th class="divider" colspan="2">Interactions</th></tr><tr><th>Drug Interactions</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Drug</th><th style="width: 75%"></th></tr></thead><tbody><tr><td><a href="/drugs/DB00630">Alendronate</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB00537">Ciprofloxacin</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB00720">Clodronate</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB08826">Deferiprone</a></td><td>Deferiprone may decrease gastrointestinal absorption by chelating to other ions. Interaction is significant so monitor closely. </td></tr><tr><td><a href="/drugs/DB00618">Demeclocycline</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB00254">Doxycycline</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB06210">Eltrombopag</a></td><td>Levels of eltrombopag are decreased due to GI inhibition. Separate administration by at least 4 hours. </td></tr><tr><td><a href="/drugs/DB00467">Enoxacin</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB01077">Etidronic acid</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB01044">Gatifloxacin</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB01155">Gemifloxacin</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB00365">Grepafloxacin</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB00710">Ibandronate</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB01235">L-DOPA</a></td><td>Iron decreases the absorption of dopa derivatives</td></tr><tr><td><a href="/drugs/DB01137">Levofloxacin</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB00451">Levothyroxine</a></td><td>Iron decreases the absorption of levothyroxine</td></tr><tr><td><a href="/drugs/DB00978">Lomefloxacin</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB00931">Methacycline</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB00968">Methyldopa</a></td><td>Iron decreases the absorption of dopa derivatives</td></tr><tr><td><a href="/drugs/DB01017">Minocycline</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB00218">Moxifloxacin</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB00688">Mycophenolate mofetil</a></td><td>Oral iron decreases the absorption of mycophenolate-mofetil</td></tr><tr><td><a href="/drugs/DB01059">Norfloxacin</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB01165">Ofloxacin</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB00595">Oxytetracycline</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB00487">Pefloxacin</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB00859">Penicillamine</a></td><td>The multivalent agent decreases the effect of penicillamine</td></tr><tr><td><a href="/drugs/DB00884">Risedronate</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB01405">Temafloxacin</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB00759">Tetracycline</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB00685">Trovafloxacin</a></td><td>Formation of non-absorbable complexes</td></tr></tbody></table></td></tr><tr><th>Food Interactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table>